Omeros logo

Omeros Share Price Today

(NASDAQ: OMER)

Omeros share price is $8.36 & ₹727.06 as on 6 Mar 2025, 2.30 'hrs' IST

$8.36

0.38

(4.76%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Omeros share price in Dollar and Rupees. Guide to invest in Omeros stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Omeros, along with analyst recommendations, forecasts, and comprehensive financials.

Omeros share price movements

  • Today's Low: $7.81
    Today's High: $8.37

    Day's Volatility :6.63%

  • 52 Weeks Low: $2.61
    52 Weeks High: $13.60

    52 Weeks Volatility :80.79%

Omeros (OMER) Returns

PeriodOmeros CorporationSector (Health Care)Index (Russel 2000)
3 Months
-28.11%
2.1%
0.0%
6 Months
101.52%
-4.1%
0.0%
1 Year
80.95%
2.2%
0.0%
3 Years
27.88%
11.8%
-11.6%

Omeros (OMER) Key Statistics

in dollars & INR

Previous Close
$7.98
Open
$8.0
Today's High
$8.365
Today's Low
$7.81
Market Capitalization
$462.4M
Today's Volume
$122.9K
52 Week High
$13.6
52 Week Low
$2.612
Revenue TTM
$-30.0M
EBITDA
$-172.5M
Earnings Per Share (EPS)
$-3.07
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-576.33%

How to invest in Omeros Stock (OMER) from India?

It is very easy for Indian residents to invest directly in Omeros from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Omeros stock in both Indian Rupees (INR) and US Dollars (USD). Search for Omeros or OMER on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Omeros or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Omeros shares which would translate to 0.104 fractional shares of Omeros as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Omeros, in just a few clicks!

Returns in Omeros (OMER) for Indian investors in Rupees

The Omeros stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Omeros investment value today

Current value as on today

₹1,94,532

Returns

₹94,532

(+94.53%)

Returns from Omeros Stock

₹89,569 (+89.57%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Omeros (OMER)

-88%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Omeros Stock from India on INDmoney has decreased by -88% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Omeros

  • BlackRock Inc

    7.42%

  • Ingalls & Snyder LLC

    6.92%

  • Vanguard Group Inc

    5.42%

  • D. E. Shaw & Co LP

    3.17%

  • Stifel Financial Corp

    2.73%

  • Geode Capital Management, LLC

    2.31%

Analyst Recommendation on Omeros

Buy

    66%Buy

    33%Hold

    0%Sell

Based on 9 Wall street analysts offering stock ratings for Omeros(by analysts ranked 0 to 5 stars)

Based on 9 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
3
2
2
Sell
0
0
0

Analyst Forecast on Omeros Stock (OMER)

What analysts predicted

Upside of 330.62%

Target:

$36.00

Current:

$8.36

Insights on Omeros Stock (Ticker Symbol: OMER)

  • Price Movement

    In the last 6 months, OMER stock has moved up by 101.5%
  • OMER vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 22.8%

Omeros Technicals Summary

Sell

Neutral

Buy

Omeros is currently in a neutral trading position according to technical analysis indicators.

Omeros (OMER) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Omeros Corporation logo
-12.6%
101.52%
80.95%
27.88%
-51.43%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Omeros Corporation logo
1.43
NA
-0.17
-2.98
-5.76
-0.27
NA
-2.66
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Omeros Corporation logo
Buy
$462.4M
-51.43%
1.43
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Omeros

Omeros Corporation, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting immunologic diseases, including complement-mediated diseases, cancers, and addictive and compulsive disorders. The company's products under development include Narsoplimab (OMS721/MASP-2) that has completed pivotal trial for hematopoietic stem-cell transplant-associated thrombotic microangiopathy (TA-TMA); that is in Phase III clinical trial for the treatment of immunoglobulin A nephropathy (IgAN); and Phase II clinical trial to treat COVID-19. It also develops OMS1029 that is in phase I clinical trials for long-acting second-generation antibody targeting lectin pathway disorders; OMS906 that has completed phase II clinical trials for Paroxysmal nocturnal hemoglobinuria, complement 3 glomerulopathy, and other alternative pathway disorders; and OMS527 that is in phase I clinical trials for addictions and compulsive disorders, and movement disorders. In addition, the company's products under preclinical development comprise MASP-2, a pro-inflammatory protein target for the treatment of lectin pathway disorders; MASP-3 small-molecule inhibitors for alternative pathway disorders; and Adoptive T-Cell and Chimeric Antigen Receptor (CAR) T-Cell Therapies and Immunomodulators/Immunotoxins/Cancer Vaccines for the treatment of various cancers. Omeros Corporation was incorporated in 1994 and is headquartered in Seattle, Washington.
Organization
Omeros
Employees
198
CEO
Dr. Gregory A. Demopulos M.D.
Industry
Health Technology

Management People of Omeros

NameTitle
Dr. Gregory A. Demopulos M.D.
Co-Founder, Chairman, CEO & President
Mr. Peter B. Cancelmo J.D.
VP, General Counsel & Corporate Secretary
Dr. Pamela Pierce Palmer M.D., Ph.D.
Co-Founder
Mr. David J. Borges
VP of Finance, Chief Accounting Officer & Treasurer
Dr. George A. Gaitanaris M.D., Ph.D.
Chief Scientific Officer & VP of Science
Mr. Peter W. Williams
Vice President of Human Resources
Dr. Catherine A. Melfi Ph.D.
Chief Regulatory Officer & VP of Regulatory Affairs and Quality Systems
Ms. Nadia Dac
VP & Chief Commercial Officer
Dr. Andreas Grauer M.D.
VP & Chief Medical Officer
Mr. David W. Ghesquiere
Chief Business Development Officer

Important FAQs about investing in OMER Stock from India :

What is Omeros share price today?

Omeros share price today stands at $8.36, Open: $8.00 ; Previous Close: $7.98 ; High: $8.37 ; Low: $7.81 ; 52 Week High: $13.60 ; 52 Week Low: $2.61.

The stock opens at $8.00, after a previous close of $7.98. The stock reached a daily high of $8.37 and a low of $7.81, with a 52-week high of $13.60 and a 52-week low of $2.61.

Can Indians buy Omeros shares?

Yes, Indians can invest in the Omeros (OMER) from India.

With INDmoney, you can buy Omeros at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Omeros at zero transaction cost.

How can I buy Omeros shares from India?

It is very easy to buy Omeros from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Omeros (OMER) be purchased?

Yes, you can buy fractional shares of Omeros with INDmoney app.

What are the documents required to start investing in Omeros stocks?

To start investing in Omeros, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Omeros Stock (OMER)?

Today’s highest price of Omeros (OMER) is $8.37.

Today’s lowest price of Omeros (OMER) is $7.81.

What is today's market capitalisation of Omeros?

Today's market capitalisation of Omeros OMER is 462.4M

What is the 52 Week High and Low Range of Omeros Stock (OMER)?

  • 52 Week High

    $13.60

  • 52 Week Low

    $2.61

What are the historical returns of Omeros (OMER)?

  • 1 Month Returns

    -12.6%

  • 3 Months Returns

    101.52%

  • 1 Year Returns

    80.95%

  • 5 Years Returns

    -51.43%

Who is the Chief Executive Officer (CEO) of Omeros ?

Dr. Gregory A. Demopulos M.D. is the current Chief Executive Officer (CEO) of Omeros.